A01K 2227/107
Rabbit
A01K2227/107 (Rabbit) appears on 53 US grants and 100 published applications in this corpus.
Search patents in A01K- Granted patents
- 53
- Published applications
- 100
- Assignees
- 67
- Inventors
- 206
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 0 | 5 |
| 2003 | 3 | 10 |
| 2004 | 2 | 11 |
| 2005 | 2 | 4 |
| 2006 | 3 | 5 |
| 2007 | 3 | 2 |
| 2008 | 1 | 3 |
| 2009 | 3 | 3 |
| 2010 | 2 | 4 |
| 2011 | 0 | 4 |
| 2012 | 0 | 2 |
| 2013 | 1 | 5 |
| 2014 | 1 | 2 |
| 2015 | 0 | 3 |
| 2016 | 2 | 4 |
| 2017 | 0 | 3 |
| 2018 | 3 | 2 |
| 2019 | 3 | 8 |
| 2020 | 3 | 6 |
| 2021 | 6 | 4 |
| 2022 | 3 | 3 |
| 2023 | 2 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of an ocular infection, composition and methods thereof20 Jan 2026US 12,527,814 B2City University of Hong Kong
- Genetically modified non-human animals and methods for producing heavy chain-only antibodies5 Dec 2023US 11,832,598 B2Akeagen, Inc.
- Genetically modified rabbit expressing an exogenous protein in milk16 May 2023US 11,647,737 B2Asc Therapeutics Inc.
- Compositions and methods for treating leber's hereditary optic neuropathy17 May 2022US 11,332,741 B1Wuhan Neurophth Biotechnology Limited Company
- Factor VII composition having a substantially homogenous isoelectric point22 Feb 2022US 11,254,920 B2Laboratoire Francais Du Fractionnement Et Des Biotechnologies
- Method for constructing an animal model of open-angle glaucoma15 Jan 2026US 2026/0013482 A1The Second Xiangya Hospital of Central South University
- Methods of Treating Retinal Degenerative Diseases Using AIMP2-DX2 and Optionally a Target Sequence for miR-142 and Compositions Thereof11 Sep 2025US 2025/0281573 A1
- Non-meiotic allele introgression5 Dec 2024US 2024/0397918 A1Recombinetics, Inc.
- Suppression-Replacement Gene Therapy21 Mar 2024US 2024/0093202 A1Mayo Foundation for Medical Education and Research
- Method for treating ocular surface diseases22 Feb 2024US 2024/0058369 A1
Most cited
By later US patents
- Lysosomal proteins produced in the milk of transgenic animals92US 6,118,045 AAcademic Hospital · 2000
- Production of humanized antibodies in transgenic animals68US 7,129,084 B2Therapeutic Human Polyclonals, Inc. · 2006
- Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk64US 6,204,431 B1Abbott Laboratories · 2001
- Transgenic rabbit that expresses a functional human lipoprotein (a)51US 6,512,161 B1Aventis Pharmaceuticals Inc. · 2003
- Treatment of Pompe's disease51US 7,351,410 B2Genzyme Therapeutic Products Limited Partnership · 2008